Home » Stocks » DHR

Danaher Corporation (DHR)

Stock Price: $297.63 USD 4.75 (1.62%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $298.88 +1.25 (0.42%) Jul 29, 4:11 PM
Market Cap 209.09B
Revenue (ttm) 26.72B
Net Income (ttm) 5.45B
Shares Out 714.50M
EPS (ttm) 7.52
PE Ratio 39.59
Forward PE 33.67
Dividend $0.78
Dividend Yield 0.26%
Trading Day July 29
Last Price $297.63
Previous Close $292.88
Change ($) 4.75
Change (%) 1.62%
Day's Open 293.37
Day's Range 293.01 - 298.69
Day's Volume 1,776,828
52-Week Range 191.85 - 298.69

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Does Danaher (DHR) have what it takes to be a top stock pick for momentum investors? Let's find out.

3 hours ago - Zacks Investment Research

CROX, ISRG, MIDD, and DHR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2021

Other stocks mentioned: CROX, ISRG, MIDD
1 day ago - Zacks Investment Research

DHR, CLFD, HCA, FBP, and SNBR qualified as the day's Momentum Picks Using Driehaus Strategy.

Other stocks mentioned: CLFD, FBP, HCA, SNBR
1 day ago - Zacks Investment Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 days ago - Zacks Investment Research

AMERSHAM, United Kingdom, July 27, 2021 /PRNewswire/ -- An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, will expand manufacturing capacity...

2 days ago - PRNewsWire

The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed its portfolio for the second quarter of the year this week.

Other stocks mentioned: ABT, AGTI, HAE, HUM, INOV, TXG
2 days ago - GuruFocus

BREA, Calif., July 26, 2021 /PRNewswire/ -- Beckman Coulter, a global clinical diagnostics leader, today announced that it has entered into definitive agreements with Quidel Corporation to obtain all ri...

3 days ago - PRNewsWire

Danaher's (DHR) Q2 results reflect strength in segmental businesses, the impact of pandemic-led tailwinds and improved margins. Projection for core sales growth, including Cytiva, increases for 2021.

1 week ago - Zacks Investment Research

Danaher (DHR) delivered earnings and revenue surprises of 20.59% and 7.83%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Danaher Corporation (NYSE: DHR) logged a higher profit for the second quarter as its sales grew. Adjusted EPS increased 71% Y/Y to $2.46, surpassing the estimate of $2.05.

1 week ago - Benzinga

WASHINGTON, July 22, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the second quarter 2021.  All results in this release reflect only continuing operat...

1 week ago - PRNewsWire

The stock price of Danaher, a conglomerate with products in environmental, life sciences, and diagnostics fields, has seen a 10% rise over the last twenty-one trading days, while it is up 47% over the l...

1 week ago - Forbes

Danaher (NYSE:DHR) unveils its next round of earnings this Thursday, July 22. Get prepared with Benzinga's ultimate preview for Danaher's Q2 earnings.

1 week ago - Benzinga

These companies have earnings surprise track records and charts to envy.

Other stocks mentioned: ABT, DPZ, POOL, WHR
1 week ago - Zacks Investment Research

Water sustainability is a growing concern for many investors

Other stocks mentioned: CGW, FIW, PHO, ROP, WAT
1 week ago - Zacks Investment Research

FSS vs. DHR: Which Stock Is the Better Value Option?

Other stocks mentioned: FSS
1 week ago - Zacks Investment Research

Danaher (DHR) Q2 performance is likely to have gained from the pandemic-induced demand for products, focus on innovation and synergistic gains from acquired assets.

1 week ago - Zacks Investment Research

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago - Zacks Investment Research

The 2020s could be the decade of healthcare stocks. Here are 10 companies and one ETF to watch not just for the remainder of this year, but well beyond.

Other stocks mentioned: CURLF, GSK, IQV, ISRG, JAZZ, LHCG, MRNA ...
2 weeks ago - Kiplinger

Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 weeks ago - Zacks Investment Research

WASHINGTON, June 22, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2021 on Thursday, July 22, 2021 beg...

1 month ago - PRNewsWire

When the operating income margin continues to expand, it means that the company is becoming more efficient in generating profits from its operations.

Other stocks mentioned: ACN, TMO
1 month ago - GuruFocus

5 Stocks to Ride High in Booming Diversified Operations Industry

Other stocks mentioned: CR, CSL, GE, GFF, HON, ITT
1 month ago - Zacks Investment Research

During this unsettled time, there are some great deals on great blue-chip stocks. Here are eight to consider buying now.

Other stocks mentioned: CAT, DE, GOOG, PM, TGT, TSM, UPS ...
1 month ago - InvestorPlace

Danaher (DHR) to gain from the Aldevron acquisition as it will increase growth opportunities in the genomic medicine field. The acquired assets will be integrated with Danaher's Life Sciences segment.

1 month ago - Zacks Investment Research

Danaher (DHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down ...

1 month ago - Zacks Investment Research

FRAMINGHAM, Mass.--(BUSINESS WIRE)-- #beextraordinary--SCIEX OS introduces new software with OneOmics suite in SCIEX Cloud and Molecule Profiler app.

1 month ago - Business Wire

FRAMINGHAM, Mass.--(BUSINESS WIRE)-- #SCIEX--SCIEX presents the ZenoTOF 7600 system, a new accurate mass LC-MS/MS instrument that features the proprietary Zeno trap and EAD fragmentation.

1 month ago - Business Wire

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Danaher (DHR).

1 month ago - Zacks Investment Research

Danaher Corporation (NYSE: DHR) has agreed to acquire privately-held Aldevron for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand or pr...

1 month ago - Benzinga

WASHINGTON, June 17, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced today that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a c...

1 month ago - PRNewsWire

We have narrowed down our search to five corporate bigwigs that have provided better returns than the S&P 500 Index in the past three months. These are: FDX, SHW, DHR, TGt and NVDA.

Other stocks mentioned: FDX, NVDA, SHW, TGT
1 month ago - Zacks Investment Research

The Dow Jones ticked up 20 points, the S&P 500 rose 0.1%, and the Nasdaq gained 0.2%. Make the most of today's market with the Top Buys from Q.ai's artificial intelligence.

1 month ago - Forbes

1800 FLOWERS.COM (FLWS), Polaris (PII) & Danaher (DHR) are some of the top stocks that have striking earnings growth and positive estimate revisions at present.

Other stocks mentioned: FLWS, NAVI, PII, SHW
1 month ago - Zacks Investment Research

Danaher (DHR) possesses solid growth attributes, which could help it handily outperform the market.

1 month ago - Zacks Investment Research

To protect one's portfolio from suffering huge losses, investors mostly choose stocks that bear low leverage. You may buy HZO, TITN, SPH, DHR and TD.

Other stocks mentioned: HZO, SPH, TD, TITN
1 month ago - Zacks Investment Research

Danaher (DHR), with an 11% rise in shares in the past three months, gains from solid product offerings, the pandemic-induced demand and focus on innovation. Inorganic activities too have been aiding.

1 month ago - Zacks Investment Research

WASHINGTON, June 7, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Goldman Sachs Global ...

1 month ago - PRNewsWire

WASHINGTON, May 27, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Jefferies Healthcare ...

2 months ago - PRNewsWire

There's a lot to like about the life sciences and diagnostics company, even after the COVID-19 pandemic.

2 months ago - The Motley Fool

WASHINGTON, May 13, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed A. Shane Sanders to its Board of Directors and to its Audit Committee.

2 months ago - PRNewsWire

WASHINGTON, May 5, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.21 per share of its common stock,...

2 months ago - PRNewsWire

WASHINGTON, May 4, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Healthcare Confer...

2 months ago - PRNewsWire

FSS vs. DHR: Which Stock Is the Better Value Option?

Other stocks mentioned: FSS
2 months ago - Zacks Investment Research

The life sciences and diagnostics company is a big winner of the COVID-19 pandemic.

2 months ago - The Motley Fool

The life sciences and diagnostic company is set up for another great year.

3 months ago - The Motley Fool

WASHINGTON, April 26, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), the global science and technology company, announced today the formation of a Scientific Advisory Board ("Board") ...

3 months ago - PRNewsWire

Danaher's (DHR) first-quarter 2021 revenues increase 57.9% year over year on account of impressive performance across its segments.

3 months ago - Zacks Investment Research

Danaher (DHR) delivered earnings and revenue surprises of 50.90% and 0.57%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of Danaher (NYSE:DHR) moved higher by 0.2% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 140.00% year over year to $2.52, which beat the e...

3 months ago - Benzinga

About DHR

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to t... [Read more...]

Industry
Diagnostics & Research
Founded
1969
CEO
Rainer Blair
Employees
67,000
Stock Exchange
NYSE
Ticker Symbol
DHR
Full Company Profile

Financial Performance

In 2020, Danaher's revenue was $22.28 billion, an increase of 24.42% compared to the previous year's $17.91 billion. Earnings were $3.65 billion, an increase of 21.21%.

Financial Statements

Analyst Forecasts

According to 21 analysts, the average rating for Danaher stock is "Buy." The 12-month stock price forecast is 292.32, which is a decrease of -1.78% from the latest price.

Price Target
$292.32
(-1.78% downside)
Analyst Consensus: Buy